A Cleveland Clinic study shows that bariatric surgery performed in patients with obesity and moderate to severe obstructive sleep apnea is associated...

WEDNESDAY, June 26, 2024 -- Tirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and...

Cleveland Clinic study reveals that weight loss surgery significantly reduces the risk of heart complications by 42% and the risk of death by 37% in...

THURSDAY, June 27, 2024 -- For patients with rheumatoid arthritis (RA), a detectable level of high-sensitivity cardiac troponin T (hs-cTnT) is...

Eli Lilly (LLY) files for the approval of tirzepatide to treat obstructive sleep apnea in adults with obesity in the United States. If approved, sales...

Researchers at University of California San Diego School of Medicine and international collaborators have led a worldwide, advanced study...

An analysis of data from a randomised clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib,...

THURSDAY, June 20, 2024 -- For sedentary adults with obesity/overweight and metabolic impairments, the timing of moderate-to-vigorous physical...

New research showed that tirzepatide, the compound in Zepbound, improved symptoms of obstructive sleep apnea.

New study reveals beneficial effects on patient' health after their weight loss surgery.